UPDATE : Monday, October 21, 2019
상단여백
US data crucial for Korean biosimilars after success in Europe by Nam Doo-hyun 2018-11-21 15:29
FDA OKs sale of Celltrion's HIV biosimilar by Lee Han-soo 2018-11-21 12:57
Intron Bio inks ₩750 billion licensing deal for anti-superbug drug by So Jae-hyeon 2018-11-20 15:00
Celltrion Healthcare presents research results on using biosimilars in Europe by Lee Han-soo 2018-11-19 16:57
Bridge Bio applies for idiopathic pulmonary fibrosis treatment in US by Lee Han-soo 2018-11-19 11:58
라인
Tego Science sales plunge in Q3 by Lee Han-soo 2018-11-16 14:54
NIBEC wins patent for novel peptide in US by Lee Han-soo 2018-11-16 14:40
Samsung BioLogics fiasco hardly affects biotech stocks by Nam Doo-hyun 2018-11-16 11:30
Medipost mark profit losses in Q3 by Lee Han-soo 2018-11-15 15:18
[News Focus] Biotechs to suffer shocks from Samsung BioLogics mess by So Jae-hyeon 2018-11-15 14:56
라인
Celltrion Healthcare posts ₩212.7 billion in Q3 sales by Lee Han-soo 2018-11-15 12:43
Regulators suspend trading of Samsung BioLogics on accounting fraud charges by Lee Han-soo 2018-11-14 18:28
Alteogen promote antibody-drug conjugate cancer treatment in US by Lee Han-soo 2018-11-14 16:59
GCAM opens new plasma collection centers in US by Lee Han-soo 2018-11-09 17:58
GC launches Biocon’s antidiabetic biosimilar by Lee Han-soo 2018-11-08 15:46
라인
'Biosimilar makers to benefit from new research accounting guideline' by Nam Doo-hyun 2018-11-07 11:23
Biois seeks KOSDAQ listing with ‘technology exception policy’ by So Jae-hyeon 2018-11-06 15:43
Market caps of top 20 drugmakers on KOSPI surged this year by Nam Doo-hyun 2018-11-06 15:41
Samsung BioLogics to complete Biogen’s call option by Lee Han-soo 2018-11-06 10:45
Will PharmAbcine be new force on KOSDAQ? by Nam Doo-hyun 2018-11-05 16:32
여백
여백
여백
Back to Top